What's new in respiratory infections and tuberculosis 2008-2010

被引:1
作者
Brown, Jeremy S. [1 ]
Lipman, Marc C. I. [2 ]
Zar, Heather J. [3 ]
机构
[1] Univ Coll Med Sch, Ctr Resp Res, Dept Med, Rayne Inst, London WC1E 6JJ, England
[2] Univ Coll Med Sch, Ctr Resp Med, Royal Free Hosp, London WC1E 6JJ, England
[3] Univ Cape Town, Dept Paediat & Child Hlth, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa
关键词
COMMUNITY-ACQUIRED PNEUMONIA; PULMONARY TUBERCULOSIS; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL VACCINATION; CLINICAL CHARACTERISTICS; PREDICTING MORTALITY; INTERFERON-GAMMA; BCG VACCINATION; RISK-FACTORS; INFLUENZA;
D O I
10.1136/thoraxjnl-2011-200227
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Over the past few years there have been an increasing number of research articles published in Thorax on respiratory tract infections (including tuberculosis) affecting children and adults. Although these articles cover a wide variety of areas, several broad themes can be discerned. These include greater interest in viral respiratory infections (partially stimulated by the recent influenza A pandemic), improved characterisation of who is at risk of community-acquired pneumonia and mycobacterial infection, research into better diagnostics and attempts to develop new or improved scoring scales for a range of respiratory infection syndromes. There have also been a limited number of articles on how to manage patients with respiratory infection, including describing the efficacy of prevention by vaccination. Overall, there has been a discernible emphasis on transferring advances in clinical science to actual clinical practice, with several papers using molecular methodologies or measuring levels of cytokines or other potential biomarkers to improve diagnostic accuracy in patients with lung infection. There have also been manuscripts linking specific pathogen genotypes to infection phenotype, an area that is likely to be increasingly important in explaining some of the variations in severity between patients with respiratory infection. However, many questions remain on the optimum strategies for the management and prevention of pneumonia, bronchiectasis and tuberculosis, and there remains a strong need for further clinical research in order to make substantial improvements in the management of patients with lung infection.
引用
收藏
页码:350 / 354
页数:5
相关论文
共 65 条
[1]   Extensively drug-resistant tuberculosis in the UK: 1995 to 2007 [J].
Abubakar, I. ;
Moore, J. ;
Drobniewski, F. ;
Kruijshaar, M. ;
Brown, T. ;
Yates, M. ;
Anderson, C. ;
Smith, E. G. ;
Magee, J. ;
Lipman, M. ;
McMenamin, J. ;
Ruddy, M. ;
Watson, J. M. .
THORAX, 2009, 64 (06) :512-515
[2]   Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France [J].
Andrejak, C. ;
Lescure, F-X ;
Pukenyte, E. ;
Douadi, Y. ;
Yazdanpanah, Y. ;
Laurans, G. ;
Schmit, J-L ;
Jounieaux, V. .
THORAX, 2009, 64 (04) :291-296
[3]   Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB [J].
Aspler, Anne ;
Long, Richard ;
Trajman, Anete ;
Dion, Marie-Josee ;
Khan, Kamran ;
Schwartzman, Kevin ;
Menzies, Dick .
THORAX, 2010, 65 (07) :582-587
[4]   Does early review by a respiratory physician lead to a shorter length of stay for patients with non-severe community-acquired pneumonia? [J].
Bewick, T. ;
Cooper, V. J. ;
Lim, W. S. .
THORAX, 2009, 64 (08) :709-712
[5]   Global, regional, and national causes of child mortality in 2008: a systematic analysis [J].
Black, Robert E. ;
Cousens, Simon ;
Johnson, Hope L. ;
Lawn, Joy E. ;
Rudan, Igor ;
Bassani, Diego G. ;
Jha, Prabhat ;
Campbell, Harry ;
Walker, Christa Fischer ;
Cibulskis, Richard ;
Eisele, Thomas ;
Liu, Li ;
Mathers, Colin .
LANCET, 2010, 375 (9730) :1969-1987
[6]   Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis [J].
Breen, R. A. M. ;
Barry, S. M. ;
Smith, C. J. ;
Shorten, R. J. ;
Dilworth, J. P. ;
Cropley, I. ;
McHugh, T. D. ;
Gillespie, S. H. ;
Janossy, G. ;
Lipman, M. C. I. .
THORAX, 2008, 63 (01) :67-71
[7]   Biomarkers and community-acquired pneumonia [J].
Brown, Jeremy S. .
THORAX, 2009, 64 (07) :556-+
[8]   Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia [J].
Capelastegui, A. ;
Espana, P. P. ;
Quintana, J. M. ;
Bilbao, A. ;
Menendez, R. ;
Zalacain, R. ;
Torres, A. .
THORAX, 2009, 64 (06) :496-501
[9]   Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia [J].
Chalmers, J. D. ;
Singanayagam, A. ;
Murray, M. P. ;
Scally, C. ;
Fawzi, A. ;
Hill, A. T. .
THORAX, 2009, 64 (07) :592-597
[10]   C-reactive protein is an independent predictor of severity in community-acquired pneumonia [J].
Chalmers, James D. ;
Singanayagam, Aran ;
Hill, Adam T. .
AMERICAN JOURNAL OF MEDICINE, 2008, 121 (03) :219-225